Cigna Unveils National Coverage Policy for Adolescent Depression Including TMS!

Cigna has recently updated its national policy to cover Transcranial Magnetic Stimulation (TMS) for adolescents aged 15 and older with depression. This significant change expands access to non-drug mental health treatments for teens and follows a new FDA label approval for Neuronetics, the manufacturer of the NeuroStar TMS device.

Authored by LWC Medical Director, Owen Scott Muir, M.D., this update marks an important step forward in mental health care.

This is the 901st post I've done on The Frontier Psychiatrist newsletter, and it does seem fitting that it's about progress. Also, here is a photo of Batz Maru for not reason other than my daughter loves San Rio.

Read Full Article